Novo Nordisk A/S (NONOF)
47.00
+0.19
(+0.41%)
USD |
OTCM |
Aug 24, 16:00
Novo Nordisk Market Cap : 207.78B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 207.78B |
| August 21, 2026 | 206.94B |
| August 20, 2026 | 204.81B |
| August 19, 2026 | 200.71B |
| August 18, 2026 | 198.57B |
| August 17, 2026 | 199.42B |
| August 14, 2026 | 199.56B |
| August 13, 2026 | 202.44B |
| August 12, 2026 | 202.07B |
| August 11, 2026 | 207.38B |
| August 10, 2026 | 208.95B |
| August 07, 2026 | 208.12B |
| August 06, 2026 | 200.37B |
| August 05, 2026 | 198.06B |
| August 04, 2026 | 196.72B |
| August 03, 2026 | 202.60B |
| July 31, 2026 | 203.38B |
| July 30, 2026 | 220.15B |
| July 29, 2026 | 223.34B |
| July 28, 2026 | 221.05B |
| July 27, 2026 | 217.18B |
| July 24, 2026 | 219.70B |
| July 23, 2026 | 214.94B |
| July 22, 2026 | 214.35B |
| July 21, 2026 | 220.10B |
| Date | Value |
|---|---|
| July 20, 2026 | 220.37B |
| July 17, 2026 | 224.33B |
| July 16, 2026 | 222.72B |
| July 15, 2026 | 221.59B |
| July 14, 2026 | 217.71B |
| July 13, 2026 | 219.10B |
| July 10, 2026 | 213.09B |
| July 09, 2026 | 215.21B |
| July 08, 2026 | 212.76B |
| July 07, 2026 | 220.36B |
| July 06, 2026 | 219.18B |
| July 02, 2026 | 217.07B |
| July 01, 2026 | 209.57B |
| June 30, 2026 | 209.46B |
| June 29, 2026 | 213.17B |
| June 26, 2026 | 211.37B |
| June 25, 2026 | 212.59B |
| June 24, 2026 | 212.39B |
| June 23, 2026 | 208.15B |
| June 22, 2026 | 204.82B |
| June 18, 2026 | 192.87B |
| June 17, 2026 | 195.58B |
| June 16, 2026 | 194.92B |
| June 15, 2026 | 199.40B |
| June 12, 2026 | 195.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.158T |
| ALK-Abello A/S | 8.413B |
| H. Lundbeck A/S | 6.588B |
| Dr. Reddy's Laboratories Ltd. | 10.27B |
| Neumora Therapeutics, Inc. | 277.47M |
Market Cap Related Metrics
| PE Ratio | 11.49 |
| PS Ratio | 4.061 |
| PEG Ratio | 0.9116 |
| Price to Book Value | 6.139 |
| Price to Free Cash Flow | 28.35 |
| Price | 47.00 |
| Earnings Yield | 8.71% |
| PEGY Ratio | 0.699 |
| Operating PE Ratio | 8.950 |
| Normalized PE Ratio | 11.04 |